Pfizer
Utility Patent Applications
Last updated:
List of all Pfizer patents 264 in total
| Status | Patent |
|---|---|
Application | Utility: DOSING REGIMEN OF AVELUMAB FOR THE TREATMENT OF CANCER Filling date: 13 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: METABOLITES OF GLP1R AGONISTS Filling date: 13 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: REAL-TIME TRACKING AND MANAGEMENT OF STANDARD WORKFLOWS Filling date: 13 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: METABOLITES OF GLP1R AGONISTS Filling date: 13 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: (AZA)Benzothiazolyl Substituted Pyrazole Compounds Filling date: 13 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: STABLE LIQUID ANTIBODY FORMULATION Filling date: 13 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: TIME TO RESOLUTION OF AXITINIB-RELATED ADVERSE EVENTS Filling date: 13 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE Filling date: 13 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS Filling date: 13 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: Nitrile-Containing Antiviral Compounds Filling date: 13 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE COMPOUND AND USE THEREOF Filling date: 13 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: Methods for purifying bacterial polysaccharides Filling date: 13 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: Method of treatment of Chronic Low Back Pain Filling date: 13 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF Filling date: 13 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: COMBINATION OF A CDK INHIBITOR AND A PIM INHIBITOR Filling date: 13 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: CRYSTALLINE FORM OF A CDK INHIBITOR Filling date: 13 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: Antibodies to MAdCAM Filling date: 13 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: CDCP1-TARGETED THERAPIES Filling date: 13 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: CD1a ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: CYCLIN DEPENDENT KINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE Filling date: 13 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: Pharmaceutical Compositions and Methods Comprising A Combination of a Benzoxazole Transthyretin Stabilizer and an Additional Therapeutic Agent Filling date: 13 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: Nitrile-Containing Antiviral Compounds Filling date: 13 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: SSI CELLS WITH PREDICTABLE AND STABLE TRANSGENE EXPRESSION AND METHODS OF FORMATION Filling date: 13 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: RECOMBINANT VACCINIA VIRUS Filling date: 13 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: Combinations For Treatment Of NASH/NAFLD And Related Diseases Filling date: 13 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: BTLA FUSION PROTEIN AGONISTS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: THERAPEUTIC ANTIBODIES AND THEIR USES Filling date: 13 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof Filling date: 13 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: IMMUNOGENIC COMPOSITIONS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR Filling date: 13 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: AMINOPYRIMIDINYL DERIVATIVES Filling date: 13 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: Immunogenic Compositions for Use in Pneumococcal Vaccines Filling date: 13 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: Dosage Regimen for TFPI Antagonists Filling date: 13 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: CRYSTALLINE FORMS OF LORLATINIB MALEATE Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: POLYMORPH FORM OF A MONOPHOSPHATE HYDRATE SALT OF A KNOWN TETRAHYDROISOQUINOLINE DERIVATIVE Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: Combination for Treating Cancer Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: GLYCOCONJUGATION PROCESS Filling date: 13 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: AMINOPYRIMIDINYL COMPOUNDS Filling date: 13 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: Combinations for Treating Cancer Filling date: 13 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: COMPOUNDS AND USES THEREOF TO TREAT TUMORS IN A SUBJECT Filling date: 13 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: COMBINATIONS OF TGF-BETA INHIBITORS AND CDK INHIBITORS FOR CANCER TREATMENTS Filling date: 13 Sep 2025 Issue date: 11 Nov 2021 |
Showing 1 to 50 of 264 patents.